Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction
Authors:
- Christian BosseauCBChristian Bosseau
- Cecila LindeCLCecila Linde
- on behalf of the KaRen InvestigatorsOIon behalf of the KaRen Investigators
Open Access
- 4 March 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 18 (6) , 629-635
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome with various phenotypes and outcomes. The prognostic relevance of echocardiography and the E/e′ ratio has previously been reported. We sought to study in addition, the value of estimated pulmonary pressure and left atrial size for diagnosing and determining a prognosis for HFpEF-patients in a prospective multi-centric cohort. Patients with an acute-HF event accompanied with NT-proBNP >300 pg/mL (BNP >100 pg/mL) and LVEF >45% were included (n = 237) and clinically reassessed using echo-Doppler after 4–8 weeks of HF treatment as part of the prospective KaRen HFpEF study. A core-centre performed the echocardiographic analyses. A combined primary endpoint of either HF hospitalizations and mortality over a span of 18-month, or simply mortality (secondary endpoint) were used. The mean LVEF was 62 ± 7%, E/e’:12.9 ± 6.0, left atrial volume index (LAVI): 48.1 ± 15.9 ml/m2, TR: 2.9 ± 0.9 m/s. Patients with both LAVI > 40 ml/m2 and TR > 3.1 m/s had a significantly greater risk of death or heart failure related hospitalization than others (P = 0.014 after adjustment). The combination of enlarged LA and elevated estimated pulmonary pressure has a strong prognostic impact in patients suffering from HFpEF. Our results indicate that such patients constitute a risk group in HFpEF which requires dedicated medical attention. NCT00774709Keywords
This publication has 21 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- New Echocardiographic Predictors of Clinical Outcome in Patients Presenting with Heart Failure and a Preserved Left Ventricular Ejection Fraction: A Subanalysis of the Ka (Karolinska) Ren (Rennes) StudyEuropean Journal of Heart Failure, 2015
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypesEuropean Heart Journal, 2014
- Association Between Cardiovascular vs. Non-Cardiovascular Co-Morbidities and Outcomes in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2014
- Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) studyArchives of Cardiovascular Diseases, 2014
- Update of the Echocardiography Core Syllabus of the European Association of Cardiovascular Imaging (EACVI)European Heart Journal - Cardiovascular Imaging, 2013
- Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fractionEuropean Heart Journal, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection FractionCirculation, 2011
- Rationale and Design of the Karolinska-Rennes (KaRen) Prospective Study of Dyssynchrony in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2009